Related Experiment Videos
Predicting outcomes in renal cell carcinoma.
Brian R Lane1, Michael W Kattan
1Glickman Urological Institute, The Cleveland Clinic Foundation, OH 44195, USA.
Current Opinion in Urology
|August 12, 2005
Summary
Renal cell carcinoma nomograms help predict cancer recurrence after surgery. These tools improve patient counseling and treatment planning for better outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Renal cell carcinoma (RCC) is a lethal genitourinary malignancy with high mortality rates.
- A significant percentage of patients present with metastatic disease or experience recurrence after surgery.
- Current treatments for advanced RCC offer limited benefits to most patients.
Purpose of the Study:
- To review the role of prognostic nomograms in managing renal cell carcinoma.
- To highlight the clinical utility of these algorithms in predicting patient outcomes.
Main Methods:
- Review of clinical, histologic, and molecular factors influencing RCC recurrence.
- Analysis of established prognostic nomograms for RCC survival and recurrence post-nephrectomy.
Main Results:
- Numerous factors have been identified as risk indicators for RCC recurrence.
- Several validated nomograms incorporate these factors to predict survival and recurrence probabilities.
Conclusions:
- Renal cell carcinoma nomograms provide more accurate prognostication for patient counseling.
- These tools aid in treatment planning and identify high-risk individuals for clinical trials.